Penguin Random House, author portrait placeholder image

Christopher P. Cannon, M.D.

Christopher P. Cannon, MD, is an associate professor of medicine at Harvard Medical School in the cardiovascular division at Brigham and Women's Hospital in Boston. He is a senior investigator of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and over the past two decades has been the principal investigator for more than ten international clinical trials in the area of heart attacks and prevention. The trials include PROVE IT-TIMI 22, which showed that "lower is better" for cholesterol and changed international guidelines, and CLARITY-TIMI 28, which showed that giving heart attack patients clopidogrel (Plavix) can prevent future heart attacks.

Books for LGBTQIA+ Pride Month

In June we celebrate Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, and Asexual + (LGBTQIA+) Pride Month, which honors the 1969 Stonewall riots in Manhattan. Pride Month is a time to both celebrate the accomplishments of those in the LGBTQ+ community and recognize the ongoing struggles faced by many across the world who wish to live

Read more